Pain Relief Investigation of NeuroModulation Therapy in Adult Humans

This study has been terminated.

Sponsors and Collaborators:	Fralex Therapeutics PharmaNet
Information provided by:	Fralex Therapeutics
ClinicalTrials.gov Identifier:	NCT00253032

Purpose

The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.

Condition	Intervention	Phase
Chronic Musculoskeletal Pain	Device: PRIMA	Phase III

U.S. FDA Resources

Study Type:	Interventional
Official Title:	PRIMA Study: Pain Relief Investigation of NeuroModulation Therapy in an Adult Population: A Double Blind, Randomized, Multicenter, Placebo Controlled Trial.

Contacts and Locations

No Contacts or Locations Provided

More Information

Study ID Numbers:	F05001
Study First Received:	November 11, 2005
Last Updated:	March 2, 2006
ClinicalTrials.gov Identifier:	NCT00253032
Health Authority:	United States: Food and Drug Administration; Canada: Health Canada

Study placed in the following topic categories:

Pain

ClinicalTrials.gov processed this record on January 14, 2009